Purpose: To describe a case of T-cell lymphoma with bilateral vitreous involvement. Methods: A case report was reviewed, and a literature review, including search terms such as “anaplastic large-cell lymphoma (ALCL)” and “T-cell lymphoma with ocular involvement”, was performed. Results: A 56-year-old man presented with slurred speech, left-sided weakness, and floaters in his right eye. He was found to have an enhancing right frontal lobe mass with biopsy positive for ALCL. The right eye demonstrated 2+ vitreous cell, with a vitreous biopsy consistent with ALCL. His floaters resolved, and the patient was asymptomatic until he developed floaters in his left eye 1½ years later. A subsequent vitreous biopsy revealed recurrence of ALCL in the fellow eye. Conclusions: ALCL is a rare T-cell lymphoma uncommonly reported as having vitreous infiltration.
SobolewskaBCheeSPZaguiaF, et al. Vitreoretinal lymphoma. Cancers (Basel). 2021;13(16):3921.
2.
FerreriAJReniMPasiniF, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology. 2002;58(10):1513-1520.
3.
HiranoYMiyawakiSTanakaS, et al. Clinical features and prognostic factors for primary anaplastic large cell lymphoma of the central nervous system: a systematic review. Cancers (Basel). 2021;13(17):4358.
4.
ZhangXRChienPNNamSYHeoCY.Anaplastic large cell lymphoma: molecular pathogenesis and treatment. Cancers (Basel). 2022;14(7):1650. doi:10.3390/cancers14071650
5.
ParkCHwangSKimDHuhHOhJ.Anaplastic large cell lymphoma involving anterior segment of the eye. Korean J Ophthalmol. 2014;28:108-112.
6.
ClarkeBLegodiEChrystalVGovenderD.Systemic anaplastic large cell lymphoma presenting with conjunctival involvement. Arch Ophthalmol. 2003;121(4):568-570.
7.
SegalZCohenISzvalbSWeyl-Ben-ArushMRehanyU.Solitary extranodal anaplastic large cell lymphoma, Ki-1+, of the eyelid. Am J Ophthalmol. 1997;124(1):105-107.
8.
HuFLinJChiangIYehK.T-cell malignant lymphoma with conjunctival involvement. Am J Ophthalmol. 1998;125:717-719.
9.
ChaputFAmerRBaglivoE, et al. Intraocular T-cell lymphoma: clinical presentation, diagnosis, treatment, and outcome. Ocul Immunol Inflamm. 2017;25(5):639-648.
10.
DavisJLVicianaALRuizP.Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol. 1997;124(3): 362-372.
11.
ChanCCWhitcupSMSolomonDNussenblattRB.Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120(5):671-673.
12.
WhiteVAGascoyneRDPatonKE.Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. Arch Ophthalmol. 1999;117:761-765.
13.
BhatiaSPaulinoACBuattiJMMayrNAWenBC.Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys. 2002;54(3):818-823.
14.
IsobeKEjimaYTokumaruS, et al. Treatment of primary intraocular lymphoma with radiation therapy: a multi-institutional survey in Japan. Leuk Lymphoma. 2006;47(9):1800-1805.
15.
Levy-ClarkeGAGreenmanDSievingPC, et al. Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. Surv Ophthalmol. 2008;53(3): 285-295.
16.
SmithJRRosenbaumJTWilsonDJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002; 109(9):1709-1716.
17.
SlaterDN.The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol. 2005;153(5):874-880.
